SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-014044
Filing Date
2017-12-01
Accepted
2017-12-01 09:00:33
Documents
5
Period of Report
2017-11-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 27978
2 ex99-1.htm EX-99.1 2930
3 image_001.jpg GRAPHIC 148625
4 image_002.jpg GRAPHIC 130776
5 image_003.jpg GRAPHIC 71800
  Complete submission text file 0001493152-17-014044.txt   516049
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 171232797
SIC: 2835 In Vitro & In Vivo Diagnostic Substances